Skip to main content
Year archive

ALK-Abelló — 2022 filings

All 53 regulatory filings released by ALK-Abelló (ALK) in 2022, sourced directly from the official regulator.

53 Filings
2022 Period
2022 filings (53)
Filing Released Lang
Board/Management Information 2022
Board/Management Information
2022-11-30 English
Board/Management Information 2022
Board/Management Information
2022-11-30 Danish
Management change at ALK
Board/Management Information
2022-11-30 Danish
Management change at ALK
Board/Management Information
2022-11-30 English
Director's Dealing 2022
Director's Dealing
2022-08-25 Danish
Director's Dealing 2022
Director's Dealing
2022-08-25 English
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
Director's Dealing
2022-08-25 Danish
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
Director's Dealing
2022-08-25 Danish
Director's Dealing 2022
Director's Dealing
2022-08-16 Danish
Director's Dealing 2022
Director's Dealing
2022-08-16 English
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
Director's Dealing
2022-08-16 Danish
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
Director's Dealing
2022-08-16 Danish
Interim / Quarterly Report 2022
Interim / Quarterly Report H1 2022
2022-08-11 English
Interim / Quarterly Report 2022
Interim / Quarterly Report H1 2022
2022-08-11 English
Six-month interim report (Q2) 2022
Interim / Quarterly Report H1 2022
2022-08-11 Danish
Six-month interim report (Q2) 2022
Interim / Quarterly Report H1 2022
2022-08-11 Danish
Earnings Release 2022
Earnings Release H1 2022
2022-08-04 Danish
Earnings Release 2022
Earnings Release H1 2022
2022-08-04 English
ALK upgrades its full-year financial outlook
Earnings Release H1 2022
2022-08-04 Danish
ALK upgrades its full-year financial outlook
Earnings Release H1 2022
2022-08-04 English
Regulatory Filings 2022
Regulatory Filings
2022-06-27 Danish
Regulatory Filings 2022
Regulatory Filings
2022-06-27 English
ALK begins clinical trial of its SLIT-tablet for the treatment of peanut allergy
Regulatory Filings
2022-06-27 Danish
ALK begins clinical trial of its SLIT-tablet for the treatment of peanut allergy
Regulatory Filings
2022-06-27 English
Director's Dealing 2022
Director's Dealing
2022-05-19 Danish
Director's Dealing 2022
Director's Dealing
2022-05-19 English
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
Director's Dealing
2022-05-19 Danish
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
Director's Dealing
2022-05-19 English
Director's Dealing 2022
Director's Dealing
2022-05-17 Danish
Director's Dealing 2022
Director's Dealing
2022-05-17 English
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
Director's Dealing
2022-05-17 Danish
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
Director's Dealing
2022-05-17 English
Total share capital and voting rights
Share Issue/Capital Change
2022-03-29 Danish
Total share capital and voting rights
Share Issue/Capital Change
2022-03-29 Danish
Total share capital and voting rights
Share Issue/Capital Change
2022-03-29 English
Total share capital and voting rights
Share Issue/Capital Change
2022-03-29 Danish
Remuneration Information 2022
Remuneration Information
2022-03-24 English
Remuneration Information 2022
Remuneration Information
2022-03-24 Danish
Grant of share options and performance shares to members of the Board of Management and key employees
Board/Management Information
2022-03-24 Danish
Grant of share options and performance shares to members of the Board of Management and key employees
Remuneration Information
2022-03-24 English
Investor Presentation 2022
Investor Presentation
2022-03-03 Danish
Regulatory Filings 2022
Regulatory Filings
2022-03-03 English
Clinical trial waiver in China opens door to 2022 registration filing for ALK’s dust mite allergy tablet
Regulatory Filings
2022-03-03 Danish
Clinical trial waiver in China opens door to 2022 registration filing for ALK’s dust mite allergy tablet
Regulatory Filings
2022-03-03 Danish
Director's Dealing 2022
Director's Dealing
2022-03-02 Danish
Director's Dealing 2022
Director's Dealing
2022-03-02 English
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
Director's Dealing
2022-03-02 Danish
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
Director's Dealing
2022-03-02 Danish
Annual Report 2021
Annual Report FY 2021
2022-02-08 English
Annual Report 2022
Annual Report
2022-02-08 Danish
Annual Report (ESEF) 2021
Annual Report (ESEF) FY 2021
2022-02-08 English
Annual report 2021: ALK delivers strong sales growth of 12% with tablet sales up 29% and EBITDA up 35%
Annual Report FY 2021
2022-02-08 English
Annual report 2021: ALK delivers strong sales growth of 12% with tablet sales up 29% and EBITDA up 35%
Regulatory Filings
2022-02-08 English